Literature DB >> 12167518

Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission.

Kuan-Pin Su1, Sy-Jye C Leu, Yi-Yuan Yang, Winston W Shen, Yech-Mei Chou, Shang-Ying M Tsai.   

Abstract

BACKGROUND: Activation of inflammatory response system (IRS) is suggested by increased levels of plasma soluble interleukin-2 receptor (sIL-2R) in patients with bipolar mania. The reasons for changes in stimulated interferon-gamma (IFN-gamma) and interleukin-10 (IL-10) production in bipolar mania along with subsequent remission remain unclear.
METHODS: We measured phytohemagglutinin (PHA)-stimulated IFN-gamma and IL-10 production in 20 physically healthy inpatients aged between 18 and 45 years with bipolar mania (DSM-IV) using Young Mania Rating Scale (YMRS) scores > or = 26 and in subsequent remission (YMRS < or = 12), as well as in 15 age- and sex-matched healthy normal controls.
RESULTS: The mean values of IFN-gamma production in patients in acute mania and in subsequent remission were significantly lower than those of healthy controls (P=0.0004, P=0.0005, respectively). There was no significant difference in IL-10 production between bipolar patients in acute mania as well as in subsequent remission and healthy controls. In acute mania, the mean values of IFN-gamma and IL-10 production in medicated patients (n = 13) did not differ from those of drug-free patients (n = 7). Other clinical variables had no effect on IFN-gamma and IL-10 production. LIMITATION: The uncontrolled medication, small sample size of the bipolar individuals, and some immune re-measurements prior to full remission periods, limit generalization from the data in this study.
CONCLUSION: Reduced production of IFN-gamma without alternation of IL-10 in bipolar mania and subsequent remission suggest that the immune modulation may vary in patients with different major psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167518     DOI: 10.1016/s0165-0327(01)00369-x

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  10 in total

1.  Effect of Increased Neutrophil-to-Lymphocyte Ratio (NLR) and Decreased Mean Platelet Volume (MPV) Values on Inflammation in Acute Mania.

Authors:  Hasan Mayda; Ahmet Ahsen; Erman Bağcioğlu; Ahmet Öztürk; Bülent Bahçeci; Etem Soyuçok; Erol Başpinar; Memnune Sena Ulu
Journal:  Noro Psikiyatr Ars       Date:  2016-12-01       Impact factor: 1.339

Review 2.  Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.

Authors:  Joanna K Soczynska; Sidney H Kennedy; Hanna O Woldeyohannes; Samantha S Liauw; Mohammad Alsuwaidan; Christina Y Yim; Roger S McIntyre
Journal:  Neuromolecular Med       Date:  2010-12-17       Impact factor: 3.843

Review 3.  Depression and cardiovascular disease: an update on how course of illness may influence risk.

Authors:  Jess G Fiedorowicz
Journal:  Curr Psychiatry Rep       Date:  2014-10       Impact factor: 5.285

Review 4.  Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers.

Authors:  Ather Muneer
Journal:  Psychiatry Investig       Date:  2015-11-20       Impact factor: 2.505

5.  The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models.

Authors:  B T Baune; M Stuart; A Gilmour; H Wersching; W Heindel; V Arolt; K Berger
Journal:  Transl Psychiatry       Date:  2012-03-13       Impact factor: 6.222

Review 6.  The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder.

Authors:  Helena Kyunghee Kim; Wenjun Chen; Ana Cristina Andreazza
Journal:  Neural Plast       Date:  2015-05-13       Impact factor: 3.599

7.  Proliferation and apoptosis of T lymphocytes in patients with bipolar disorder.

Authors:  Krzysztof Pietruczuk; Katarzyna A Lisowska; Karol Grabowski; Jerzy Landowski; Jacek M Witkowski
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

8.  Transcriptome analysis and functional characterization of cerebral organoids in bipolar disorder.

Authors:  Annie Kathuria; Kara Lopez-Lengowski; Magdalena Vater; Donna McPhie; Bruce M Cohen; Rakesh Karmacharya
Journal:  Genome Med       Date:  2020-04-19       Impact factor: 11.117

9.  Chemokines in bipolar disorder: trait or state?

Authors:  Izabela Guimarães Barbosa; Natália Pessoa Rocha; Moisés Evandro Bauer; Aline Silva de Miranda; Rodrigo Barreto Huguet; Helton José Reis; Patricia A Zunszain; Mark A Horowitz; Carmine M Pariante; Antônio Lúcio Teixeira
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-15       Impact factor: 5.270

Review 10.  Significantly Higher Prevalence Rate of Asthma and Bipolar Disorder Co-Morbidity: A Meta-Analysis and Review Under PRISMA Guidelines.

Authors:  Ming-Kung Wu; Hung-Yu Wang; Yen-Wen Chen; Pao-Yen Lin; Ching-Kuan Wu; Ping-Tao Tseng
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.